EUVIMEDEUVIMED entdecken
Crossref

Association of Somatic KRAS Variants with Osteolysis in Arteriovenous Malformations

María San Basilio, Lara Rodríguez-Laguna, Paloma Triana Junco iD, Víctor Martínez-Glez, Carla Ramirez-Amoros iD, Carlos Delgado-Miguel iD, Juan P Rodriguez-Arias, Juan C Lopez-Gutierrez

European Journal of Pediatric Surgery · 01.10.2025 · 35 (05) · 362-368

DOI: 10.1055/a-2540-3621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pediatric Surgery, erschienen am 01.10.2025. Verfasst von María San Basilio und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Surgery, Hospital Universitario La Paz, Paseo de la Castellana, Madrid, Spain. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins p21(ras), Osteolysis, Arteriovenous Malformations. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER) FUNDS., Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER) FUNDS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genetic study of vascular anomalies provides a better understanding of their etiopathogenesis and allows the use of targeted therapies. Activating KRAS pathogenic variants promote cell proliferation by activating MAPK and PI3K signalling pathways, which have been associated with the pathogenesis of vascular anomalies, especially high-flow ones such as arteriovenous malformations (AVMs). AVMs' genomic landscape is extensive, and a genotype–phenotype correlation has not been shown. In this study, we aimed to prove an association between KRAS gene mutations and the presence of osteolysis in patients with AVMs. Herein, we present a clinical–molecular retrospective study of patients with AVMs, bone involvement, and KRAS pathogenic variants. A retrospective review of patients with AVMs and KRAS somatic variants followed by the Vascular Anomalies Unit at our institution was performed. All patients present bone involvement. We analyzed demographics, clinical features (AVMs location, phenotype), treatment received, and response to treatment. Previous imaging studies were used to assess bone involvement. Genetic studies were performed by high-throughput sequencing using a custom-designed panel. Of the 77 patients with AVMs currently followed in our clinic, 60 (77.9%) had genetic testing, and 19 (31.6%) presented a KRAS somatic activating variant and were therefore included in the study. There were 12 women and 7 men aged 10 to 79 years. When studying radiographies or CT scans, we found that all 19 patients associated osteolysis adjacent to the AVMs. Regarding the KRAS variants, the most frequent one was p.Gly12Asp, followed by p.Gln61His and p.Gly13Arg. Additionally, we reviewed imaging studies from the other 41 patients with AVMs and different pathogenic variants such as MAP2K1, RASA1, and BRAF, and did not find osteolysis. We have described for the first time the relationship between somatic, activating KRAS pathogenic variants and osteolysis in patients with AVMs. Early detection of these KRAS alterations in this type of patient should lead us to rule out bone involvement. Moreover, identifying these mutations may help guide targeted therapies, potentially preventing the development of osteolysis and improving patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins p21(ras)OsteolysisArteriovenous MalformationsHumansMaleFemaleRetrospective StudiesChildAdolescentMutationAdultYoung AdultMiddle Aged

Substanzen

Proto-Oncogene Proteins p21(ras)KRAS protein, human

Autor:innen und Institutionen

  • Department of Pediatric Surgery, Hospital Universitario La Paz, Paseo de la Castellana, Madrid, Spain.
  • Institute of Medical and Molecular Genetics, INGEMM-IdiPAZ, IdiPAZ, Madrid, Spain.
  • Center for Genomic Medicine, Parc Taulí Hospital Universitari, Sabadell, Spain.
  • Department of Pediatric Surgery, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain.
  • Department of Maxilofacial Surgery, Hospital La Paz, Madrid, Spain.
  • Division of Vascular Anomalies, Department of Pediatric Surgery, La Paz Children's Hospital, Madrid, Spain.

ORCID-Profile: Paloma Triana Junco, Carla Ramirez-Amoros, Carlos Delgado-Miguel

Förderung

  • Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER) FUNDS.
  • Instituto de Salud Carlos III (ISCIII), Fondo Europeo de Desarrollo Regional (FEDER) FUNDS

Zitieren

APA

San Basilio, M., Rodríguez-Laguna, L., Triana Junco, P., Martínez-Glez, V., Ramirez-Amoros, C., Delgado-Miguel, C., Rodriguez-Arias, J. P., & Lopez-Gutierrez, J. C. (2025). Association of Somatic KRAS Variants with Osteolysis in Arteriovenous Malformations. European Journal of Pediatric Surgery, 35(05), 362-368. https://doi.org/10.1055/a-2540-3621

Vancouver

San Basilio M, Rodríguez-Laguna L, Triana Junco P, Martínez-Glez V, Ramirez-Amoros C, Delgado-Miguel C, et al. Association of Somatic KRAS Variants with Osteolysis in Arteriovenous Malformations. European Journal of Pediatric Surgery. 2025;35(05):362-368. doi:10.1055/a-2540-3621

BibTeX
@article{SanBasilio2025,
  author = {San Basilio, María and Rodríguez-Laguna, Lara and Triana Junco, Paloma and Martínez-Glez, Víctor and Ramirez-Amoros, Carla and Delgado-Miguel, Carlos and Rodriguez-Arias, Juan P and Lopez-Gutierrez, Juan C},
  title = {Association of Somatic KRAS Variants with Osteolysis in Arteriovenous Malformations},
  journal = {European Journal of Pediatric Surgery},
  year = {2025},
  volume = {35},
  number = {05},
  pages = {362--368},
  doi = {10.1055/a-2540-3621}
}
Kostenlos starten →